Skip to main content

Austin D. Kim

Equibles does not estimate personal net worth.

Get an email with a short summary when Acadia Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get ACAD alerts

About Austin D. Kim

Austin D. Kim is recorded as General Counsel at Acadia Pharmaceuticals Inc (ACAD). The newest filing on record that lists Austin D. Kim as General Counsel at Acadia Pharmaceuticals Inc (ACAD) is dated May 1, 2023. The proxy statement of Acadia Pharmaceuticals Inc reports total compensation of $2,024,546 for Austin D. Kim in fiscal 2023, including a base salary of $509,433. Disclosed compensation is on record for 6 fiscal years. Acadia Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acadia Pharmaceuticals Inc includes Catherine Owen Adams (CEO and Board Member), Stephen R. Biggar (Chairman and Board Member), Mark C. Schneyer (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Acadia Pharmaceuticals Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Acadia Pharmaceuticals Inc (ACAD) $509,433 $2,024,546
2022 Acadia Pharmaceuticals Inc (ACAD) $489,042 $4,537,092
2021 Acadia Pharmaceuticals Inc (ACAD) $470,180 $2,330,704
2020 Acadia Pharmaceuticals Inc (ACAD) $448,751 $1,747,288
2019 Acadia Pharmaceuticals Inc (ACAD) $435,913 $1,906,126
2018 Acadia Pharmaceuticals Inc (ACAD) $195,704 $2,126,212

Recent activity

No call appearances or filed executive changes recorded yet.